Article: PC-SPES analysis confirms presence of synthetic compounds. (Industry News).

A two-year study presented at the 93rd Annual Meeting of the American Association for Cancer Research (AACR) has confirmed the presence of synthetic compounds including the estrogenic drug diethylstilbestrol (DES) in PC-SPES, the herbal supplement used by prostate cancer patients. Investigators uncovered the presence of DES, as well as the blood thinner warfarin and the anti-inflammatory drug indomethacin in samples of PC-SPES manufactured from 1996 through 2001. The researchers used HPLC analysis to ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!